Skip to content
10-Q

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001477932-14-006259

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 14, 2014 52.19M sh
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$1.39M
Operating Cash Flow Q3 2014 · Sep 30, 2013 $323.74K
Stockholders Equity Q3 2014 · Sep 30, 2014 $10.62M
Stockholders Equity Q3 2014 · Dec 31, 2013 $11.43M
Stockholders Equity Q3 2014 · Dec 31, 2012 $10.95M
Current Liabilities Q3 2014 · Sep 30, 2014 $7.83M
Current Liabilities Q3 2014 · Dec 31, 2013 $10.19M
Total Liabilities Q3 2014 · Sep 30, 2014 $7.83M
Total Liabilities Q3 2014 · Dec 31, 2013 $10.19M
Current Assets Q3 2014 · Sep 30, 2014 $11.95M
Current Assets Q3 2014 · Dec 31, 2013 $14.6M
Total Assets Q3 2014 · Sep 30, 2014 $18.44M
Total Assets Q3 2014 · Dec 31, 2013 $21.62M
Sga Expense Q3 2014 · Sep 30, 2014 $363.84K
Sga Expense Q3 2014 · Sep 30, 2014 $1.77M
Sga Expense Q3 2014 · Sep 30, 2013 $768.22K
Sga Expense Q3 2014 · Sep 30, 2013 $2.26M
Rd Expense Q3 2014 · Sep 30, 2014 $396.01K
Rd Expense Q3 2014 · Sep 30, 2014 $426.44K
Rd Expense Q3 2014 · Sep 30, 2013 $26.98K
Rd Expense Q3 2014 · Sep 30, 2013 $48.45K
Net Income Q3 2014 · Sep 30, 2014 −$5.27K
Net Income Q3 2014 · Sep 30, 2014 −$732.63K
Net Income Q3 2014 · Dec 31, 2013 $127.27K
Net Income Q3 2014 · Sep 30, 2013 $411.97K
Net Income Q3 2014 · Sep 30, 2013 $355.58K
Operating Income Q3 2014 · Sep 30, 2014 −$19.84K
Operating Income Q3 2014 · Sep 30, 2014 −$706.49K
Operating Income Q3 2014 · Sep 30, 2013 $539.01K
Operating Income Q3 2014 · Sep 30, 2013 $252.96K
Gross Profit Q3 2014 · Sep 30, 2014 $1.03M
Gross Profit Q3 2014 · Sep 30, 2014 $2.78M
Gross Profit Q3 2014 · Sep 30, 2013 $2.1M
Gross Profit Q3 2014 · Sep 30, 2013 $4.72M
Revenue Q3 2014 · Sep 30, 2014 $2.01M
Revenue Q3 2014 · Sep 30, 2014 $6.58M
Revenue Q3 2014 · Sep 30, 2013 $4.31M
Revenue Q3 2014 · Sep 30, 2013 $10.99M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $6.23M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $6.07M
Capex Q3 2014 · Sep 30, 2013 $217.55K